By Yakubu LAAH InvestAdvocate
Lagos (INVESTADVOCATE)-GlaxoSmithKline Consumer Nigeria Plc (GSK Nigeria) Tuesday announced the appointment of Jonathan Girling as Non-Executive Director of the Company with effect from August 28, 2013.
The Company also notified the Nigerian Stock Exchange (NSE) of the resignation of Sameer Goel as a Non-Executive Director of the company with effect from July 31, 2013.
Girling graduated from the King’s College, University of London in 1994 with a BSc (Honours) Business Management Upper Second Class Honours.
He started his working career as External Relations & International Marketing Assistant, King’s College London. Mr. Girling joined GSK in March 1997 as Assistant Product Manager, GSK Toothbrush Category, UK and rose through the ranks as follows: December 2001 – Group Brand Manager, Lucozade Physical & Mental Energy Category, February 2003 – Category Marketing Director, Mouth Clinic Brands, Oral Care UK.
In January 2004, he was Global Innovation Director, Global Sensodyne Future Team, GSK, December 2004 – Global Strategy & Innovation Director, Global Aquafresh Brand, GSK July 2008 – Vice President & General Manager, GSK Consumer Healthcare, Southern Africa, May 2011 – Vice President & Global Business Leader, GSK Global Pain Management Category and July 2013 – Vice President & General Manager, GSK Consumer Healthcare, Africa.
This is coming on the heels of the announcement from GlaxoSmithKline that SBF Japan is expected to its Lucozade and Ribena brands for 1.35 billion pounds ($2.1 billion) to help it expand into new markets.
